Alexo Therapeutics Company Profile

Aggregated data from the web about Alexo Therapeutics

Company Name	Alexo Therapeutics
Website	alxoncology.com
Snippet	ALX Oncology is a clinical-stage immuno-oncology company developing therapies that block the CD47 myeloid checkpoint mechanism exploited by cancer cells to evade the immune system. Our lead candidate, ALX148, is a fusion protein that comprises an engineered high affinity CD47 binding domain of SIRPα linked to an inactive Fc region of human immunoglobulin.
Country	united states
Founded	2015.0
Website	alexotherapeutics.com
Industry	biotechnology
linkedin	linkedin.com/company/alexo-therapeutics
size_range	11 - 50
display_url	alexotherapeutics.com
Headquarters	south san francisco, california, united states
Number of employees	8

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.